Krieg AM - Search Results

1

A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.

Waag DM, McCluskie MJ, Zhang N, Krieg AM. Waag DM, et al. Among authors: krieg am. Infect Immun. 2006 Mar;74(3):1944-8. doi: 10.1128/IAI.74.3.1944-1948.2006. Infect Immun. 2006. PMID: 16495571 Free PMC article.

2

CpG DNA is an effective oral adjuvant to protein antigens in mice.

McCluskie MJ, Weeratna RD, Krieg AM, Davis HL. McCluskie MJ, et al. Among authors: krieg am. Vaccine. 2000 Nov 22;19(7-8):950-7. doi: 10.1016/s0264-410x(00)00215-2. Vaccine. 2000. PMID: 11115721

3

Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration.

Noll BO, McCluskie MJ, Sniatala T, Lohner A, Yuill S, Krieg AM, Schetter C, Davis HL, Uhlmann E. Noll BO, et al. Among authors: krieg am. Biochem Pharmacol. 2005 Mar 15;69(6):981-91. doi: 10.1016/j.bcp.2004.12.013. Biochem Pharmacol. 2005. PMID: 15748709

4

Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.

McCluskie MJ, Krieg AM. McCluskie MJ, et al. Among authors: krieg am. Curr Top Microbiol Immunol. 2006;311:155-78. doi: 10.1007/3-540-32636-7_6. Curr Top Microbiol Immunol. 2006. PMID: 17048708 Review.

5

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM. Vollmer J, et al. Among authors: krieg am. Immunology. 2004 Oct;113(2):212-23. doi: 10.1111/j.1365-2567.2004.01962.x. Immunology. 2004. PMID: 15379982 Free PMC article.

6

Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Wongratanacheewin S, Kespichayawattana W, Intachote P, Pichyangkul S, Sermswan RW, Krieg AM, Sirisinha S. Wongratanacheewin S, et al. Among authors: krieg am. Infect Immun. 2004 Aug;72(8):4494-502. doi: 10.1128/IAI.72.8.4494-4502.2004. Infect Immun. 2004. PMID: 15271908 Free PMC article.

7

Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes.

Ray NB, Krieg AM. Ray NB, et al. Among authors: krieg am. Infect Immun. 2003 Aug;71(8):4398-404. doi: 10.1128/IAI.71.8.4398-4404.2003. Infect Immun. 2003. PMID: 12874318 Free PMC article.

8

Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.

Chen Y, Lenert P, Weeratna R, McCluskie M, Wu T, Davis HL, Krieg AM. Chen Y, et al. Among authors: krieg am. Gene Ther. 2001 Jul;8(13):1024-32. doi: 10.1038/sj.gt.3301482. Gene Ther. 2001. PMID: 11438837

9

Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.

Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman SL. Gramzinski RA, et al. Among authors: krieg am. Infect Immun. 2001 Mar;69(3):1643-9. doi: 10.1128/IAI.69.3.1643-1649.2001. Infect Immun. 2001. PMID: 11179339 Free PMC article.

10

CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.

Amemiya K, Meyers JL, Rogers TE, Fast RL, Bassett AD, Worsham PL, Powell BS, Norris SL, Krieg AM, Adamovicz JJ. Amemiya K, et al. Among authors: krieg am. Vaccine. 2009 Apr 6;27(16):2220-9. doi: 10.1016/j.vaccine.2009.02.016. Epub 2009 Feb 13. Vaccine. 2009. PMID: 19428836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters